The Study to Evaluate Efficacy and Safety of MY-REPT Capsule in Primary, Liver Transplantation Recipients (MYLT1)

NCT01766518 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Evidence of Liver Transplantation

Interventions

DRUG: Mycophenolate mofetil

Sponsor

Chong Kun Dang Pharmaceutical